Low-dose methazolamide and intraocular pressure.
Sixteen patients with increased intraocular pressure (over 20 mm Hg) received 25 and 50 mg of oral methazolamide, twice daily, during consecutive weeks and then 500 mg (Sequels) of acetazolamide. The two methazolamide regimens produced significant decreases in intraocular pressure. Acetazolamide treatment resulted in a greater decrease in intraocular pressure but more systemic acidosis and side effects.
D000086:Acetazolamide / Q000009:adverse effects / Q000494:pharmacology; D000138:Acidosis / Q000139:chemically induced; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001769:Blood; D001835:Body Weight / Q000187:drug effects; D002257:Carbonic Anhydrase Inhibitors / Q000494:pharmacology; D002924:Ciliary Body / Q000187:drug effects / Q000201:enzymology; D003864:Depression, Chemical; D004573:Electrolytes / Q000097:blood; D005260:Female; D005901:Glaucoma / Q000503:physiopathology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008704:Methazolamide / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D008875:Middle Aged; D013830:Thiadiazoles / Q000494:pharmacology*
D002257:Carbonic Anhydrase Inhibitors; D004573:Electrolytes; D013830:Thiadiazoles; D000086:Acetazolamide; D008704:Methazolamide